Quick guide: target of rapamycin.
Dennis
Patrick B
PB
Wright State University, 3640 Colonel Glenn Highway, Dayton, Ohio 45435, USA.
Thomas
George
G
D018797:Cell Cycle Proteins; D017321:Clinical Trials, Phase I as Topic; D005656:Fungal Proteins / Q000737:chemistry* / Q000378:metabolism*; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D008970:Molecular Weight; D009369:Neoplasms / Q000188:drug therapy; D019869:Phosphatidylinositol 3-Kinases; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000737:chemistry* / Q000378:metabolism*; D020033:Protein Isoforms / Q000737:chemistry / Q000378:metabolism; D011494:Protein Kinases / Q000737:chemistry / Q000378:metabolism; D029701:Saccharomyces cerevisiae Proteins; D020123:Sirolimus / Q000494:pharmacology* / Q000627:therapeutic use; D058570:TOR Serine-Threonine Kinases
D018797:Cell Cycle Proteins; D005656:Fungal Proteins; D019869:Phosphatidylinositol 3-Kinases; D017853:Phosphotransferases (Alcohol Group Acceptor); D020033:Protein Isoforms; D011494:Protein Kinases; D029701:Saccharomyces cerevisiae Proteins; D020123:Sirolimus; D058570:TOR Serine-Threonine Kinases; C546842:MTOR protein, human; C083324:TOR1 protein, S cerevisiae